Historically I have been a supporter of Creso Pharma, but I believe the CPH Board have well & truly stitched up retail investors with this deal, which was supposed to value CPH at A$0.63 per share. This would be the case if the deal was a cash for scrip deal. However the CPH share price has since been on the decline, currently trading at A$0.43, likely due to the fact that it's a scrip for scrip deal as is detailed in their company announcement on 7th June 2019 (see link below), and as the linked marketwatch article below notes;
'the purchase price for the Creso Pharma shares will be satisfied by the issuance of PharmaCielo common shares ("PharmaCielo Shares") priced at C$7.6166 per PharmaCielo Share being the 3-day volume weighted average trading price for the PharmaCielo Shares representing an exchange ratio of a 0.0775 PharmaCielo Shares per each Creso Pharma share'.
If anyone has been monitoring PCLO, they would have seen that the share price has since devalued from C$7.61, and is today trading at C$5.33, which would likely explain the decline in the CPH share price over that period, and why it is now again trading at pre-deal prices.
I'll be voting "No" for this deal and in the absence of a much better offer!
https://www.asx.com.au/asxpdf/20190607/pdf/445p489rz7c4nq.pdf
https://www.marketwatch.com/press-release/pharmacielo-to-acquire-international-cannabis-company-creso-pharma-for-a122-million-2019-06-06?mod=mw_quote_news
Note: sentiment change from Buy to Hold, and a borderline Sell for me now with this deal.
- Forums
- ASX - By Stock
- CPH
- If cph or pclo price doesn't increase vote NO?
If cph or pclo price doesn't increase vote NO?, page-6
-
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CPH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online